A series of nucleophilic addition reactions and α-C–H substitution reactions of an imine-containing ligand 2-(2-((((1 H -pyrrol-2-yl)methylene)amino)methyl)-1 H -pyrrol-1-yl)- N, N -dimethylethan-1-amine (HL1) were reported. The reactions of HL1 with 0.5 and 2 equiv of n Bu 2 Mg, respectively, gave two complexes of compositions [Mg(L1) 2 ] ( 1 ) and [Mg 2 (L2) 2 ] ( 2 ) (H 2 L2 = N -((1-(2-(dimethylamino)ethyl)-1 H -pyrrol-2-yl)methyl)-1-(1 H -pyrrol-2-yl)pentan-1-amine). The nucleophilic addition of n Bu 2 Mg to the C═N bond of the HL1 ligand occurred in the process for the formation of 2 . Treatment of HL1 with 2 and 1 equiv of n BuLi generated [Li 2 (L3) 2 ] ( 3 ) (HL3 = 2-(2-(((1-(1 H -pyrrol-2-yl)pentylidene)amino)methyl)-1 H -pyrrol-1-yl)- N, N -dimethylethan-1-amine) and [Li 2 (L1) 2 ] ( 4 ). An α-C–H substitution of the HC═NR moiety of the HL1 ligand triggered by n BuLi was discovered in the preparation of 3 . The formation of 3 demonstrates a new concept for the C–C coupling that involved inert C–H bond activation of HC═NR skeleton. The reactions of HL1 with MeLi, sec -BuLi, and tert-BuLi, respectively, were also examined. The products for both the nucleophilic addition of organolithium reagents to the C═N bond and α-C–H substitution of the HC═NR moiety of the HL1 ligand were determined. The mechanisms for the formations of 2 and 3 were rationalized by DFT calculations. The hydroboration reactions catalyzed by 2 were investigated, and these reactions characterize ample substrate scope, very good yields, and high selectivity.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: